-
Add to Cart The item has been addedAb176554-100μgMogamulizumab (anti-CCR4) is a defucosylated humanized recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab (anti-CCR4) can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab (anti-CCR4) can be used in -
Add to Cart The item has been addedAb176554-10mgMogamulizumab (anti-CCR4) is a defucosylated humanized recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab (anti-CCR4) can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab (anti-CCR4) can be used in -
Add to Cart The item has been addedAb176554-1mgMogamulizumab (anti-CCR4) is a defucosylated humanized recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab (anti-CCR4) can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab (anti-CCR4) can be used in -
Add to Cart The item has been addedAb176554-5mgMogamulizumab (anti-CCR4) is a defucosylated humanized recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab (anti-CCR4) can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab (anti-CCR4) can be used in -
Add to Cart The item has been addedAb176214-100μgNarnatumab (anti-RON) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab (anti-RON) can be used for the research of cancer.（注：Kd中的d为下标）Purity>95% -
Add to Cart The item has been addedAb176214-10mgNarnatumab (anti-RON) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab (anti-RON) can be used for the research of cancer.（注：Kd中的d为下标）Purity>95% -
Add to Cart The item has been addedAb176214-1mgNarnatumab (anti-RON) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab (anti-RON) can be used for the research of cancer.（注：Kd中的d为下标）Purity>95% -
Add to Cart The item has been addedAb176214-5mgNarnatumab (anti-RON) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab (anti-RON) can be used for the research of cancer.（注：Kd中的d为下标）Purity>95% -
Add to Cart The item has been addedAb176557-100μgNarsoplimab (anti-MASP2) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab (anti-MASP2) can be used in research of hematopoietic stem-cell -
Add to Cart The item has been addedAb176557-10mgNarsoplimab (anti-MASP2) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab (anti-MASP2) can be used in research of hematopoietic stem-cell -
Add to Cart The item has been addedAb176557-1mgNarsoplimab (anti-MASP2) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab (anti-MASP2) can be used in research of hematopoietic stem-cell -
Add to Cart The item has been addedAb176557-5mgNarsoplimab (anti-MASP2) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab (anti-MASP2) can be used in research of hematopoietic stem-cell
